// App-Quantinova.ai

168 : The Development of Psoriasis in Patients on Biological Response Modifiers

Researchers

Presenter

  • Jacob Karsh

Principal Investigators

  • N/A

Medical Centers

  • Univ of Ottawa, Ottawa, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Dermatology

Disease

  • Psoriasis

Biomarkers

  • N/A

Drug/Treatment

  • Adalimumab

  • Infliximab

  • Etanercept

  • CHS-0214

  • Abatacept

  • golimumab

  • Rituximab

Outcome

  • Unknown

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved